ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.1013A>G (p.Asp338Gly)

dbSNP: rs199474773
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000817222 SCV000957772 pathogenic Neurofibromatosis, type 1 2024-03-01 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 338 of the NF1 protein (p.Asp338Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of neurofibromatosis type I (PMID: 9298829, 30014477, 31730495, 33911094; Invitae). ClinVar contains an entry for this variant (Variation ID: 68297). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NF1 protein function with a positive predictive value of 95%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
GeneDx RCV000059149 SCV002599728 likely pathogenic not provided 2022-11-04 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 24803665, 9298829, 31730495, 33911094, Kamis2021[article], 30014477)
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000817222 SCV005045648 likely pathogenic Neurofibromatosis, type 1 2024-05-29 criteria provided, single submitter clinical testing
UniProtKB/Swiss-Prot RCV000059149 SCV000090678 not provided not provided no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.